80 FR 69972 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 218 (November 12, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 218 (November 12, 2015)
| Page Range | 69972-69972 | |
| FR Document | 2015-28661 |
[Federal Register Volume 80, Number 218 (Thursday, November 12, 2015)] [Notices] [Page 69972] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-28661] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI T32 Institutional Training Grants. Date: December 10, 2015. Time: 9:00 a.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Suite 7189, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Stephanie L. Constant, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7189, Bethesda, MD 20892, 301-443-8784, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: November 5, 2015. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015-28661 Filed 11-10-15; 8:45 am] BILLING CODE 4140-01-P
![69972 Federal Register / Vol. 80, No. 218 / Thursday, November 12, 2015 / Notices
the risk of cardiovascular events in Notice of this meeting is given under DEPARTMENT OF HEALTH AND
patients with coronary heart disease. the Federal Advisory Committee Act (5 HUMAN SERVICES
FDA intends to make background U.S.C. app. 2).
material available to the public no later National Institutes of Health
Dated: November 2, 2015.
than 2 business days before the meeting.
If FDA is unable to post the background Jill Hartzler Warner, National Heart, Lung, and Blood
material on its Web site prior to the Associate Commissioner for Special Medical Institute; Notice of Closed Meeting
meeting, the background material will Programs.
Pursuant to section 10(d) of the
be made publicly available at the [FR Doc. 2015–28672 Filed 11–10–15; 8:45 am]
Federal Advisory Committee Act, as
location of the advisory committee BILLING CODE 4164–01–P
amended (5 U.S.C. App.), notice is
meeting, and the background material
hereby given of the following meeting.
will be posted on FDA’s Web site after
The meeting will be closed to the
the meeting. Background material is DEPARTMENT OF HEALTH AND public in accordance with the
available at http://www.fda.gov/ HUMAN SERVICES provisions set forth in sections
AdvisoryCommittees/Calendar/
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
default.htm. Scroll down to the National Institutes of Health
as amended. The grant applications and
appropriate advisory committee meeting
National Heart, Lung, and Blood the discussions could disclose
link.
Procedure: Interested persons may Institute; Notice of Closed Meeting confidential trade secrets or commercial
present data, information, or views, property such as patentable material,
orally or in writing, on issues pending Pursuant to section 10(d) of the and personal information concerning
before the committee. Written Federal Advisory Committee Act, as individuals associated with the grant
submissions may be made to the contact amended (5 U.S.C. App.), notice is applications, the disclosure of which
person on or before November 30, 2015. hereby given of the following meeting. would constitute a clearly unwarranted
Oral presentations from the public will invasion of personal privacy.
The meeting will be closed to the
be scheduled between approximately public in accordance with the Name of Committee: National Heart, Lung,
12:45 p.m. and 1:45 p.m. Those and Blood Institute Special Emphasis Panel;
provisions set forth in sections NHLBI T32 Institutional Training Grants.
individuals interested in making formal
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Date: December 10, 2015.
oral presentations should notify the
as amended. The grant applications and Time: 9:00 a.m. to 11:00 a.m.
contact person and submit a brief
the discussions could disclose Agenda: To review and evaluate grant
statement of the general nature of the applications.
confidential trade secrets or commercial
evidence or arguments they wish to Place: National Institutes of Health, Suite
present, the names and addresses of property such as patentable material,
and personal information concerning 7189, 6701 Rockledge Drive, Bethesda, MD
proposed participants, and an 20892, (Telephone Conference Call).
indication of the approximate time individuals associated with the grant
Contact Person: Stephanie L. Constant,
requested to make their presentation on applications, the disclosure of which Ph.D., Scientific Review Officer, Office of
or before November 19, 2015. Time would constitute a clearly unwarranted Scientific Review/DERA, National Heart,
allotted for each presentation may be invasion of personal privacy. Lung, and Blood Institute, 6701 Rockledge
limited. If the number of registrants Name of Committee: National Heart, Lung, Drive, Room 7189, Bethesda, MD 20892, 301–
requesting to speak is greater than can 443–8784, constantsl@nhlbi.nih.gov.
and Blood Institute Special Emphasis Panel
be reasonably accommodated during the Short-term Research Education to Increase (Catalogue of Federal Domestic Assistance
scheduled open public hearing session, Diversity. Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
FDA may conduct a lottery to determine Date: December 7, 2015.
Vascular Diseases Research; 93.838, Lung
the speakers for the scheduled open Time: 10:00 a.m. to 12:00 p.m. Diseases Research; 93.839, Blood Diseases
public hearing session. The contact Agenda: To review and evaluate grant and Resources Research, National Institutes
person will notify interested persons applications. of Health, HHS)
regarding their request to speak by Place: National Institutes of Health, Suite
Dated: November 5, 2015.
November 20, 2015. 7189, 6701 Rockledge Drive, Bethesda, MD
Persons attending FDA’s advisory 20892, (Telephone Conference Call). Michelle Trout,
committee meetings are advised that the Contact Person: Stephanie L Constant, Program Analyst, Office of Federal Advisory
Agency is not responsible for providing Ph.D., Scientific Review Officer, Office of Committee Policy.
access to electrical outlets. Scientific Review/DERA, National Heart, [FR Doc. 2015–28661 Filed 11–10–15; 8:45 am]
FDA welcomes the attendance of the Lung, and Blood Institute, 6701 Rockledge BILLING CODE 4140–01–P
public at its advisory committee Drive, Room 7189, Bethesda, MD 20892, 301–
meetings and will make every effort to 443–8784, constantsl@nhlbi.nih.gov.
accommodate persons with disabilities. (Catalogue of Federal Domestic Assistance DEPARTMENT OF HEALTH AND
If you require accommodations due to a Program Nos. 93.233, National Center for HUMAN SERVICES
disability, please contact Stephanie L. Sleep Disorders Research; 93.837, Heart and
National Institutes of Health
Begansky at least 7 days in advance of Vascular Diseases Research; 93.838, Lung
the meeting. Diseases Research; 93.839, Blood Diseases Center for Scientific Review; Notice of
FDA is committed to the orderly and Resources Research, National Institutes Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
conduct of its advisory committee of Health, HHS)
meetings. Please visit our Web site at Pursuant to section 10(d) of the
Dated: November 5, 2015.
http://www.fda.gov/ Federal Advisory Committee Act, as
AdvisoryCommittees/ Michelle Trout, amended (5 U.S.C. App.), notice is
AboutAdvisoryCommittees/ Program Analyst, Office of Federal Advisory hereby given of the following meetings.
ucm111462.htm for procedures on Committee Policy. The meetings will be closed to the
public conduct during advisory [FR Doc. 2015–28650 Filed 11–10–15; 8:45 am] public in accordance with the
committee meetings. BILLING CODE 4140–01–P provisions set forth in sections
VerDate Sep<11>2014 18:15 Nov 10, 2015 Jkt 238001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\12NON1.SGM 12NON1](https://thefederalregister.org/doc/80_FR_70190/page/1.svg)
Document Created: 2015-12-14 14:53:29
Document Modified: 2015-12-14 14:53:29
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | December 10, 2015. | |
| FR Citation | 80 FR 69972 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR